sv8
Table of Contents

As filed with the Securities and Exchange Commission on August 3, 2011
Registration No. 333-
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
NXSTAGE MEDICAL, INC.
(Exact Name of Registrant as Specified in Its Charter)
     
Delaware   04-3454702
(State or Other Jurisdiction of Incorporation or   (I.R.S. Employer
Organization)   Identification No.)
     
439 South Union Street    
Lawrence, Massachusetts   01843
(Address of Principal Executive Offices)   (Zip Code)
2005 Stock Incentive Plan
(Full Title of the Plan)
Jeffrey H. Burbank
President and Chief Executive Officer
439 South Union Street
Lawrence, Massachusetts 01843

(Name and Address of Agent For Service)
(978) 687-4700
(Telephone Number, Including Area Code, of Agent For Service)
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
             
Large accelerated filer o
  Accelerated filer þ   Non-accelerated filer o (Do not check if a smaller reporting company)   Smaller reporting company o
CALCULATION OF REGISTRATION FEE
                                             
 
  Title of               Proposed Maximum     Proposed Maximum        
  Securities to be     Amount to be     Offering Price Per     Aggregate Offering     Amount of  
  Registered     Registered(1)     Share     Price     Registration Fee  
 
Common Stock, $.001 par value per share
      4,000,000 (2)     $ 18.165 (3)     $ 72,660,000 (3)     $ 8,435.83    
 
 
(1)   Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover an indeterminate number of additional shares of common stock that may become issuable under the 2005 Stock Incentive Plan (the “Plan”) by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding common shares.
 
(2)   Consists of an additional 4,000,000 shares issuable under the Plan.
 
(3)   Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Registrant’s Common Stock as reported on the Nasdaq Global Market on August 1, 2011.
 
 

 


TABLE OF CONTENTS

PART II
Item 3. Incorporation of Documents by Reference
Item 8. Exhibits
SIGNATURES
EX-5.1
EX-23.2
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed to register 4,000,000 additional shares of common stock (“Common Stock”) issuable under the 2005 Stock Incentive Plan (the “Plan”). An aggregate of 9,471,495 shares of Common Stock were previously registered on Registration Statements on Form S-8 (Registration No. 333-160109, filed on June 19, 2009, Registration No. 333-151857, filed on June 23, 2008, Registration No. 333-149225, filed on February 14, 2008, Registration No. 333-141804, filed on April 2, 2007 and Registration No. 333-130241, filed on December 9, 2005) (the “Initial Forms S-8”). As permitted by General Instruction E to Form S-8, this Registration Statement incorporates by reference the contents of the Initial Forms S-8.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference
In accordance with General Instruction E to Form S-8, the contents of the Initial Forms S-8 are hereby incorporated into this Registration Statement by reference.
Item 8. Exhibits.
The Exhibit Index contained in this Registration Statement is incorporated herein by reference.

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Lawrence, Massachusetts on this 3rd day of August, 2011.
         
 





NXSTAGE MEDICAL, INC.
 
 
  By:   /s/ Jeffrey H. Burbank    
    Jeffrey H. Burbank   
    President, Chief Executive Officer   
 
POWER OF ATTORNEY AND SIGNATURES
     We, the undersigned officers and directors of NxStage Medical, Inc., hereby severally constitute and appoint Jeffrey H. Burbank and Winifred L. Swan, and each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names in the capacities indicated below, the registration statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as officers and directors to enable NxStage Medical, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorneys, or any of them, to said registration statement and any and all amendments thereto.
     Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
             
Signature       Title   Date
 
           
/s/ Jeffrey H. Burbank
 
Jeffrey H. Burbank
      President, Chief Executive Officer and Director   August 3, 2011
 
           
 
      ( Principal executive officer )    
 
           
/s/ Robert S. Brown
 
Robert S. Brown
      Chief Financial Officer   August 3, 2011
 
           
 
      ( Principal accounting and financial officer )    
 
           
/s/ Philippe O. Chambon
 
Philippe O. Chambon
      Director   August 3, 2011
 
           
/s/ Daniel A. Giannini
 
Daniel A. Giannini
      Director   August 3, 2011
 
           
/s/ Nancy J. Ham
 
Nancy J. Ham
      Director   August 3, 2011
 
           
/s/ Earl R. Lewis
 
Earl R. Lewis
      Director   August 3, 2011
 
           
/s/ Craig W. Moore
 
Craig W. Moore
      Director   August 3, 2011
 
           
/s/ Reid S. Perper
 
Reid S. Perper
      Director   August 3, 2011
 
           
/s/ David S. Utterberg
 
David S. Utterberg
      Director   August 3, 2011
 
           
/s/ Barry M. Straube
 
Barry M. Straube
      Director   August 3, 2011

 


Table of Contents

INDEX TO EXHIBITS
         
Number   Description
       
 
  4.1 (1)  
Restated Certificate of Incorporation of the Registrant
       
 
  4.2 (1)  
Amended and Restated By-Laws of the Registrant
       
 
  4.3 (2)  
2005 Stock Incentive Plan, as amended
       
 
  4.4 (3)  
Amendment No. 3 to 2005 Stock Incentive Plan
       
 
  5.1    
Opinion of Hogan Lovells US LLP, counsel to the Registrant
       
 
  23.1    
Consent of Hogan Lovells US LLP (included in Exhibit 5.1)
       
 
  23.2    
Consent of Ernst & Young LLP
       
 
  24.1    
Power of attorney (included on the signature pages of this registration statement)
 
(1)   Previously filed with the Securities and Exchange Commission as an Exhibit to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-126711), and incorporated herein by reference.
 
(2)   Previously filed with the Securities and Exchange Commission as Appendix B to the Registrant’s Definitive Proxy Statement (File No. 000-51567) filed on April 28, 2011, and incorporated herein by reference.
 
(3)   Previously filed with the Securities and Exchange Commission as Appendix A to the Registrant’s Definitive Proxy Statement (File No. 000-51567) filed on April 28, 2011, and incorporated herein by reference.